{"id":380672,"date":"2020-11-13T07:03:30","date_gmt":"2020-11-13T12:03:30","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=380672"},"modified":"2020-11-13T07:03:30","modified_gmt":"2020-11-13T12:03:30","slug":"therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/","title":{"rendered":"TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwblockalignl { margin-left: 0px; margin-right: auto }\n.bwcellpmargin { margin-bottom: 0px; margin-top: 0px }\n.bwleftsingle { border-left: solid black 1pt }\n.bwpadl0 { padding-left: 0px }\n.bwrightsingle { border-right: solid black 1pt }\n.bwsinglebottom { border-bottom: solid black 1pt }\n.bwtablemarginb { margin-bottom: 10px }\n.bwtopsingle { border-top: solid black 1pt }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference<\/b><\/p>\n<p>BOCA RATON, Fla.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nTherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women\u2019s healthcare company, today announced that the company will participate in the Stifel 2020 Virtual Healthcare Conference.\n<\/p>\n<p>\nDetails for the presentation include:\n<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\" style=\"width:547px\">\n<tr>\n<td class=\"bwtopsingle bwsinglebottom bwleftsingle bwrightsingle bwpadl0\" style=\"width:103px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\nConference\n<\/p>\n<\/td>\n<td class=\"bwtopsingle bwsinglebottom bwrightsingle bwpadl0\" style=\"width:444px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\nStifel 2020 Virtual Healthcare Conference\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwsinglebottom bwleftsingle bwrightsingle bwpadl0\" style=\"width:103px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\nDate\n<\/p>\n<\/td>\n<td class=\"bwsinglebottom bwrightsingle bwpadl0\" style=\"width:444px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\nTuesday, November 17, 2020\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwsinglebottom bwleftsingle bwrightsingle bwpadl0\" style=\"width:103px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\nTime\n<\/p>\n<\/td>\n<td class=\"bwsinglebottom bwrightsingle bwpadl0\" style=\"width:444px\" rowspan=\"1\" colspan=\"1\">\n<p class=\"bwcellpmargin\">\n9:20 a.m. Eastern time\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\nA live webcast and replay of the presentation can be accessed on the company\u2019s website, <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.therapeuticsmd.com&amp;esheet=52326248&amp;newsitemid=20201113005039&amp;lan=en-US&amp;anchor=www.therapeuticsmd.com&amp;index=1&amp;md5=2911106f37dacdb4a6278060fbfabc7f\">www.therapeuticsmd.com<\/a>, on the Home Page or under the \u201cInvestors &amp; Media\u201d section.\n<\/p>\n<p><b>About TherapeuticsMD<\/b><\/p>\n<p>\nTherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. The Company is committed to advancing the health of women and championing awareness of their healthcare issues.\n<\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p>\nThis press release by TherapeuticsMD, Inc. may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to TherapeuticsMD\u2019s objectives, plans and strategies as well as statements, other than historical facts, that address activities, events or developments that the company intends, expects, projects, believes or anticipates will or may occur in the future. These statements are often characterized by terminology such as &#8220;believes,&#8221; &#8220;hopes,&#8221; &#8220;may,&#8221; &#8220;anticipates,&#8221; &#8220;should,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;will,&#8221; &#8220;expects,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;positioned,&#8221; &#8220;strategy&#8221; and similar expressions and are based on assumptions and assessments made in light of management\u2019s experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and the company undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, many of which are outside of the company\u2019s control. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the sections titled &#8220;Risk Factors&#8221; in the company\u2019s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as well as reports on Form 8-K, and include the following: the effects of the COVID-19 pandemic; the company\u2019s ability to maintain or increase sales of its products; the company\u2019s ability to develop and commercialize IMVEXXY\u00ae, ANNOVERA\u00ae, and BIJUVA\u00ae and obtain additional financing necessary therefor; whether the company will be able to comply with the covenants and conditions under its term loan facility; whether the company will be able to successfully divest its vitaCare business and the proceeds that may be generated by such divestiture; the potential of adverse side effects or other safety risks that could adversely affect the commercialization of the company\u2019s current or future approved products or preclude the approval of the company\u2019s future drug candidates; whether the FDA will approve the efficacy supplement for the lower dose of BIJUVA; the company\u2019s ability to protect its intellectual property, including with respect to the Paragraph IV notice letters the company received regarding IMVEXXY and BIJUVA; the length, cost and uncertain results of future clinical trials; the company\u2019s reliance on third parties to conduct its manufacturing, research and development and clinical trials; the ability of the company\u2019s licensees to commercialize and distribute the company\u2019s products; the ability of the company\u2019s marketing contractors to market ANNOVERA; the availability of reimbursement from government authorities and health insurance companies for the company\u2019s products; the impact of product liability lawsuits; the influence of extensive and costly government regulation; the volatility of the trading price of the company\u2019s common stock and the concentration of power in its stock ownership. PDF copies of the company\u2019s historical press releases and financial tables can be viewed and downloaded at its website: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.therapeuticsmd.com%2Fpressreleases.aspx&amp;esheet=52326248&amp;newsitemid=20201113005039&amp;lan=en-US&amp;anchor=www.therapeuticsmd.com%2Fpressreleases.aspx&amp;index=2&amp;md5=b034bf9a73699622034272329556f50b\">www.therapeuticsmd.com\/pressreleases.aspx<\/a>.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201113005039r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20201113005039\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20201113005039\/en\/<\/a><\/span><\/p>\n<p><b><span class=\"bwuline\">Investor Contact<br \/>\n<\/span><\/b><br \/>Nichol Ochsner<br \/>\n<br \/>Vice President, Investor Relations<br \/>\n<br \/>561-961-1900, ext. 2088<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:Nochsner@TherapeuticsMD.com\">Nochsner@TherapeuticsMD.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America Florida<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> General Health Women Consumer Health Pharmaceutical<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20201113005039\/en\/675566\/3\/THMD_rgb_%282%29.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference BOCA RATON, Fla.&#8211;(BUSINESS WIRE)&#8211; TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women\u2019s healthcare company, today announced that the company will participate in the Stifel 2020 Virtual Healthcare Conference. Details for the presentation include: Conference Stifel 2020 Virtual Healthcare Conference Date Tuesday, November 17, 2020 Time 9:20 a.m. Eastern time A live webcast and replay of the presentation can be accessed on the company\u2019s website, www.therapeuticsmd.com, on the Home Page or under the \u201cInvestors &amp; Media\u201d section. About TherapeuticsMD TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women experience through the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-380672","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference BOCA RATON, Fla.&#8211;(BUSINESS WIRE)&#8211; TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women\u2019s healthcare company, today announced that the company will participate in the Stifel 2020 Virtual Healthcare Conference. Details for the presentation include: Conference Stifel 2020 Virtual Healthcare Conference Date Tuesday, November 17, 2020 Time 9:20 a.m. Eastern time A live webcast and replay of the presentation can be accessed on the company\u2019s website, www.therapeuticsmd.com, on the Home Page or under the \u201cInvestors &amp; Media\u201d section. About TherapeuticsMD TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women experience through the &hellip; Continue reading &quot;TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-13T12:03:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201113005039r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference\",\"datePublished\":\"2020-11-13T12:03:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\\\/\"},\"wordCount\":731,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201113005039r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\\\/\",\"name\":\"TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201113005039r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2020-11-13T12:03:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201113005039r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20201113005039r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference - Market Newsdesk","og_description":"TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference BOCA RATON, Fla.&#8211;(BUSINESS WIRE)&#8211; TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women\u2019s healthcare company, today announced that the company will participate in the Stifel 2020 Virtual Healthcare Conference. Details for the presentation include: Conference Stifel 2020 Virtual Healthcare Conference Date Tuesday, November 17, 2020 Time 9:20 a.m. Eastern time A live webcast and replay of the presentation can be accessed on the company\u2019s website, www.therapeuticsmd.com, on the Home Page or under the \u201cInvestors &amp; Media\u201d section. About TherapeuticsMD TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women experience through the &hellip; Continue reading \"TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-13T12:03:30+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201113005039r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference","datePublished":"2020-11-13T12:03:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/"},"wordCount":731,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201113005039r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/","name":"TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201113005039r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2020-11-13T12:03:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201113005039r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20201113005039r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/therapeuticsmd-announces-participation-in-the-stifel-2020-virtual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=380672"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/380672\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=380672"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=380672"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=380672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}